Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma

Jennie W. Taylor, Jorg Dietrich, Elizabeth R. Gerstner, Andrew D. Norden, Mikael L. Rinne, Daniel P. Cahill, Anat Stemmer-Rachamimov, Patrick Y. Wen, Rebecca A. Betensky, Diana H. Giorgio, Kellis Snodgrass, Alison E. Randall, Tracy T. Batchelor, Andrew S. Chi

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma'. Together they form a unique fingerprint.

Medicine & Life Sciences